BioCentury
ARTICLE | Company News

KS Biomedix Holding plc, Sosei Co. Ltd. deal

June 3, 2002 7:00 AM UTC

KSB granted Sosei Japanese rights to its Phase II TransMID product to treat recurrent high grade glioma. KSB will manufacture and sell TransMID materials to Sosei, which will be responsible for develo...